Conditions: Hyperhidrosis
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 564
Healthy volunteers: no

Brief summary:
This is an open-label, long-term safety study of glycopyrronium topical wipes, enrolling up to 660 subjects with primary axillary hyperhidrosis who participated in either the DRM04-HH04 or DRM04-HH05 studies.

Detailed description:
Safety will be assessed through adverse events, blood and urine laboratory tests, physical examination, pulse and blood pressure. Local skin reactions will be assessed including burning/stinging, pruritus, edema, erythema, dryness and scaling.

Arms:
arm 1: Glycopyrronium Topical Wipes

Interventions: intervention 1: Glycopyrronium Topical Wipes
Intervention descriptions: intervention 1: Glycopyrronium Topical Wipes

Protocol document: